PATENT CLAIM ANALYSIS

Application Number: 15869635
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "231200"]

Abstract:
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Claim (Index 63):
A method of treating a solid tumor, comprising administering to a patient a compound of formula I: or a pharmaceutically acceptable salt thereof; wherein n is 0, 1, or 2; m is 0, 1, or 2, wherein m and n are not simultaneously 0; W is \u2014O\u2014 or \u2014NH\u2014; R 1  is \u2014OR; each R is independently C 1-4  alkyl or C 1-4  fluoroalkyl; R 2  is \u2014CF 3 , Cl, or Br; G is \u2014O\u2014, \u2014NR 3 \u2014, \u2014S(O) 2 \u2014, or \u2014CH(OR 4 )\u2014; R 3  is \u2014C(O)\u2014R, \u2014C(O)OR, \u2014C(O)NHR, \u2014SO 2 \u2014R, \u2014SO 2 NH 2 , \u2014C(O)\u2014C 1-4  alkylene-OH or \u2014SO 2 \u2014C 1-4  alkylene-OH; R 4  is hydrogen, C 1-4  alkyl, or C 1-4  fluoroalkyl; and R 5  is hydrogen or \u2014C(O)OR.

Metadata:
- Claim Count in Document: 176.0
- Percentile: 86.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15192491', '14636905', '13286061', '15223343', '13291706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.765974073270014
- 35 USC 102 Novelty (BERT): 0.5490591757118345
- Combined Prediction Score: 0.7442825835141961
- Mean Citation Score: 306.5282200000001
- Max Citation Score: 326.3019700000001
- Similarity Product: 292.0381564220787

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test